Correlation Between Fujian Boss and Ningbo MedicalSystem
Specify exactly 2 symbols:
By analyzing existing cross correlation between Fujian Boss Software and Ningbo MedicalSystem Biotechnology, you can compare the effects of market volatilities on Fujian Boss and Ningbo MedicalSystem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fujian Boss with a short position of Ningbo MedicalSystem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fujian Boss and Ningbo MedicalSystem.
Diversification Opportunities for Fujian Boss and Ningbo MedicalSystem
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Fujian and Ningbo is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Fujian Boss Software and Ningbo MedicalSystem Biotechno in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ningbo MedicalSystem and Fujian Boss is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fujian Boss Software are associated (or correlated) with Ningbo MedicalSystem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ningbo MedicalSystem has no effect on the direction of Fujian Boss i.e., Fujian Boss and Ningbo MedicalSystem go up and down completely randomly.
Pair Corralation between Fujian Boss and Ningbo MedicalSystem
Assuming the 90 days trading horizon Fujian Boss Software is expected to generate 2.3 times more return on investment than Ningbo MedicalSystem. However, Fujian Boss is 2.3 times more volatile than Ningbo MedicalSystem Biotechnology. It trades about 0.03 of its potential returns per unit of risk. Ningbo MedicalSystem Biotechnology is currently generating about 0.01 per unit of risk. If you would invest 1,674 in Fujian Boss Software on December 24, 2024 and sell it today you would earn a total of 47.00 from holding Fujian Boss Software or generate 2.81% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Fujian Boss Software vs. Ningbo MedicalSystem Biotechno
Performance |
Timeline |
Fujian Boss Software |
Ningbo MedicalSystem |
Fujian Boss and Ningbo MedicalSystem Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fujian Boss and Ningbo MedicalSystem
The main advantage of trading using opposite Fujian Boss and Ningbo MedicalSystem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fujian Boss position performs unexpectedly, Ningbo MedicalSystem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ningbo MedicalSystem will offset losses from the drop in Ningbo MedicalSystem's long position.Fujian Boss vs. Chen Ke Ming | Fujian Boss vs. New Hope Dairy | Fujian Boss vs. AVCON Information Tech | Fujian Boss vs. Porton Fine Chemicals |
Ningbo MedicalSystem vs. Inner Mongolia Xingye | Ningbo MedicalSystem vs. Digital China Information | Ningbo MedicalSystem vs. JCHX Mining Management | Ningbo MedicalSystem vs. ButOne Information Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stocks Directory Find actively traded stocks across global markets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |